Achim Rody

发表

Digital Breast Tomosynthesis: Technique and Cases

Joerg Barkhausen, Achim Rody, Fritz Schaefer, 2015 .

Digital Breast Tomosynthesis

Joerg Barkhausen, Achim Rody, Fritz Schaefer, 2016 .

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

Lajos Pusztai, Achim Rody, Marcus Schmidt, 2014, Genomics data.

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Christine Solbach, Dirk Metzler, 2009, Breast Cancer Research.

T cell marker metagene predicts a favourable prognosis in estrogen receptor negative and Her2 positive breast cancers.

Achim Rody, Dirk Metzler, D. Metzler, 2009 .

Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy

Arndt Hartmann, Peter J Wild, Ulrike Nitz, 2007, Clinical Cancer Research.

OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer

Tanja Fehm, Eugen Ruckhäberle, Achim Rody, 2014, Molecular oncology.

A clinically relevant gene signature in triple negative and basal-like breast cancer

Lajos Pusztai, Achim Rody, Marcus Schmidt, 2010, Breast Cancer Research.

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures

Lajos Pusztai, Eugen Ruckhäberle, Achim Rody, 2011, PloS one.

SPIO Detection and Distribution in Biological Tissue—A Murine MPI-SLNB Breast Cancer Model

Thorsten M. Buzug, Achim Rody, Ksenija Grafe, 2015, IEEE Transactions on Magnetics.

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

Kevin R Coombes, Lajos Pusztai, Eugen Ruckhäberle, 2012, European journal of cancer.